MYGN

Myriad Genetics, Inc. is a prominent molecular diagnostics firm based in Salt Lake City, Utah, renowned for its innovative genetic testing solutions that support predictive, personalized, and prognostic medicine. The company specializes in key areas such as oncology, hereditary cancer, and reproductive health, empowering healthcare professionals to make data-driven decisions tailored to individual patients. With a strong focus on advancing genetic medicine, Myriad is dedicated to expanding its product offerings and leveraging cutting-edge technology and research to enhance patient outcomes both domestically and internationally, positioning itself as a leader in the evolving landscape of healthcare.